Skip to content
Review Open access

Insomnia as a risk factor in cardiac patients and the treatment approach

2026 · Srpski medicinski casopis Lekarske komore · 0 citations · 35 references

TL;DR

The available evidence indicates that insomnia, through autonomic, neuroendocrine, inflammatory, and metabolic dysregulation, contributes to the development of hypertension, atrial fibrillation, and heart failure, with the greatest risk observed in insomnia with objectively short sleep duration.

Abstract

Introduction/Objective: Insomnia is a common sleep disorder that extends beyond the subjective feeling of poor sleep and represents a state of persistent physiological hyperarousal with important cardiovascular consequences. This review aimed to summarize the pathophysiological links between insomnia and cardiovascular disease and to compare the clinical implications of benzodiazepines and Z-hypnotics in the treatment of insomnia in cardiac patients. Methods: Using a descriptive-comparative approach, we analyzed review articles, meta-analyses, cohort studies, and observational studies addressing the relationship between insomnia, cardiovascular outcomes, and pharmacological treatment, with particular focus on differences between benzodiazepines and Z-hypnotics in cardiac patients. Results: The available evidence indicates that insomnia, through autonomic, neuroendocrine, inflammatory, and metabolic dysregulation, contributes to the development of hypertension, atrial fibrillation, and heart failure, with the greatest risk observed in insomnia with objectively short sleep duration. Longitudinal studies further suggest that persistent insomnia symptoms are associated with greater cardiovascular burden. In therapeutic terms, benzodiazepines in cardiac patients are associated with higher rates of adverse events, including heart failure rehospitalization, sudden cardiac arrest, and cardiovascular mortality, whereas available data on Z-hypnotics suggest a more favorable or neutral profile. Conclusion: Insomnia is a clinically important yet often overlooked cardiovascular risk factor. In cardiac patients, its recognition and treatment should be part of a comprehensive clinical approach, prioritizing non-pharmacological measures and carefully selected pharmacotherapy. When drug treatment is necessary, Z-hypnotics may be considered a more favorable alternative to benzodiazepines, with zopiclone standing out because of its pharmacological and clinical characteristics.

Read PDF

Similar papers

Review

preGLedni rad

Nikola M. Vojvodić, P. Otašević, J. Vuletić et al. · 1 citation
Review Sep 2026

Pharmacological Management of Insomnia in Patients with Vascular Dementia

Abstract: Introduction: Sleep disturbance is common in vascular dementia. We sought to review the management of insomnia in patients with vascular dementia. This group suffers from significantly decreased sleep efficiency, experienced disruption in sleep-wake cycles, and higher sleep disturbance, even when compared to...

Kirsty Ruyi Wang, Stephen De Souza · 0 citations
Review Oct 2026

Sleep disorders in patients with HIV.

PURPOSE OF REVIEW The improved survival of people with HIV (PWH) comes with increasing exposure to age-related, metabolic, neuropsychiatric, and cardiovascular risk factors that predispose them to sleep disorders and associated comorbidities. This narrative review examines the current burden, spectrum and causes of sle...

P. Adebayo, S. Somji, M. Makakala · 0 citations
Review Open access Aug 2026

SLEEP DISORDERS AND HYPERTENSION: PATHOPHYSIOLOGICAL MECHANISMS, EPIDEMIOLOGICAL EVIDENCE AND CLINICAL IMPLICATIONS

Background Hypertension remains a major global health challenge and an important risk factor for cardiovascular disease. Increasing evidence indicates that sleep disorders and adverse sleep patterns are associated with blood pressure dysregulation and may contribute to the development or persistence of hypertension. A...

Ewa Dapkiewicz, Dawid Gąsowski, Sylwia Haba et al. · 0 citations
Open access Sep 2026

The Relationship Between Migraine Characteristics, Sleep Quality, and Insomnia: A Hierarchical Analysis

It is suggested that a multidisciplinary approach integrating psychological screening and mood stabilization is essential for effectively managing insomnia in the migraine population, and Chronic migraineurs showed significantly higher insomnia and depression scores compared to episodic patients.

Berin Gülatar Türkoğlu, G. Sünter, Feyza Şahin et al. · 0 citations
Review Sep 2026

Non-pharmacological interventions for sleep improvement in Alzheimer's disease: A systematic review and meta-analysis

Background Sleep disturbances are common in Alzheimer's disease (AD) and may worsen neuropsychiatric symptoms, caregiver burden, quality of life, and disease progression. Non-pharmacological strategies are increasingly used because long-term hypnotic or antipsychotic treatment may be limited by safety concerns, but the...

Qian-Qian Zhang, Qian Zhou, Meng-Xia Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.